No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters
β Scribed by Edwards, SM; Dearnaley, DP; Ardern-Jones, A; Hamoudi, RA; Easton, DF; Ford, D; Shearer, R; Dowe, A; Eeles, RA
- Book ID
- 109837445
- Publisher
- Nature Publishing Group
- Year
- 1997
- Tongue
- English
- Weight
- 879 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0007-0920
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
One of the most common chromosomal abnormalities in prostate cancer involves loss of 10q22-qter. Rarely, a smaller deletion, involving 10q24-q25, has been observed, suggesting the presence of a tumor suppressor gene at this site. We previously demonstrated that the MXI1 gene maps to 10q24-q25 and is
The MSR1 gene at 8p22 has been suggested as a candidate gene for hereditary prostate cancer because germline variants have been found to be associated with the disease. Aside from a single nonsense mutation (R293X) that was found repeatedly at low frequencies in several samples, little evidence has
## Abstract Somatic mutations in the __Eβcadherin__ (__CDH1__) gene have frequently been reported in cases with diffuse gastric and lobular breast cancers. Recently, germline mutations have been identified in families with diffuse gastric cancers. In families with hereditary prostate cancer (HPC),